SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-158461
Filing Date
2024-06-11
Accepted
2024-06-10 17:32:02
Documents
13
Period of Report
2024-06-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d741804d8k.htm   iXBRL 8-K 47160
  Complete submission text file 0001193125-24-158461.txt   170044

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA atra-20240610.xsd EX-101.SCH 2853
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE atra-20240610_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atra-20240610_pre.xml EX-101.PRE 11263
16 EXTRACTED XBRL INSTANCE DOCUMENT d741804d8k_htm.xml XML 3652
Mailing Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320
Business Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320 805-623-4244
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36548 | Film No.: 241033901
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)